Marker Therapeutics, Inc. — Director's Dealing 2015

Nov 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TAPIMMUNE INC (TPIV)
CIK: 0001094038
Period of Report: 2014-02-26

Reporting Person: Grisewood Sherry (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-26	Common Stock	J	28125	$0.80	Acquired	28330	Direct

Footnotes

F1: Represents common shares issued by the Company in exchange for cancellation of amounts owed to Ms. Grisewood of $22,500 in connection with the Company's restructuring in early 2014 in which Series A preferred was issued for the debt and subsequently converted into the common stock.